A Major Shift in Peptide Regulation Is Underway The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York BPC 157 PURE Oral Spray Innovative Directions in Health Peptides! Update as of 4.15.26 from the FDA. We will know more in July. This will allow these previously labeled category 2 research peptides to category 1 and allowable for compounding by Industry Update: Interim 503A and 503B Bulks Lists New Revisions